glp 1 agonist in ckd Chronic kidney disease type diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes | Diabetologia GLP-1 receptor agonists and next-generation

FAAH is a membrane-bound enzyme that plays an important role in breaking endogenous fatty acid amides such as the endogenous cannabimimetic agent anandamide (AEA) and palmitoylethanolamide (PEA) (an anti-inflammatory agent) 71

A deficiency can hinder red blood cell production, leading to symptoms like weakness and tingling in the limbs

Dose-Response Curves: If your research allows, generating a dose-response curve can be invaluable

Low GSH levels inhibit interleukin-2 production, which induces lymphocyte proliferation (Chang et al., 1999

From botulinum toxin (aesthetics, bruxism, hair) to anthrax, aflatoxins, snake venoms, cyanotoxins, and S

SGLT2 Inhibitors and Mechanisms of Cardiovascular Benefit: A State-of-the-Art Review